Trademark: SILICON THERAPEUTICS 2272524
Word
SILICON THERAPEUTICS
Device Descrption:
ATOMIC-ORBITS IN HEXAGON
ID
2272524
Trademark Type
Figurative
Status
Protected: Registered/protected
Application Date
11 January 2022
Registration Date
11 January 2022
Renewal Date
11 January 2032
Owner(s)
Service
Goods and Services:
Class 5:
Pharmaceutical preparations for human use; biologic preparations for medical and therapeutic purposes; Pharmaceutical preparations for human use for the treatment of central nervous system, neurological, dementia, dermatological, metabolic, hematologic, infectious, auto-immune, immune deficiency, genetic, hepatological, cardiometabolic, urological, oncological, endocrine and endocrine-related, gynecological, ophthalmological, respiratory, cardiac, and pulmonary disorders, diseases and conditions; Anti-cancer preparations; Pharmaceutical preparations and substances for the prevention of cancer; Pharmaceutical preparations and substances for the treatment of cancer; Pharmaceutical preparations for the treatment of cancer; Anti-cancer preparations of chemical origin; Anti-cancer preparations of plant origin; Anti-cancer preparations of microbial origin; Biopharmaceuticals for the treatment of cancer; Compounds for treating cancer; Biological preparations for medical purposes; Biological preparations for the treatment of cancer; Viral vaccines; Pharmaceutical preparations for the treatment of viral diseases; Pharmaceutical preparations for the treatment of inflammatory diseases; Pharmaceutical preparations for the prevention of inflammatory diseases; Pharmaceuticals; Chemico-pharmaceutical preparations; Antibacterial pharmaceuticals; Anti-microbial preparations; Chemical preparations for medical purposes; Chemical preparations for pharmaceutical purposes; Vaccines; Vaccine adjuvants; Pharmaceutical preparations comprising small molecules for degrading disease-causing cellular proteins for treatment in the field of oncology; pharmaceutical and biological preparations for treatment and prevention of cancer and for the treatment and prevention of auto-immune diseases and disorders and central nervous system and neurological diseases and disorders; Biological preparations for the treatment of viral infections; Biological preparations for the treatment of inflammatory conditions; Biological preparations for the treatment of age-related degenerative diseases; Biological preparations for the treatment of microbial, fungal and viral infections; Chemical preparations for pharmaceutical or medical purposes, namely, for the treatment of age-related degenerative diseases and cancers; Pharmaceutical preparations for the treatment and prevention of cancer; Pharmaceutical preparations for the treatment and prevention of viral infections; Pharmaceutical preparations for the treatment and prevention of microbial, fungal and viral infections; Pharmaceutical preparations for the treatment and prevention of inflammatory conditions; Pharmaceutical preparations for the treatment and prevention of age-related degenerative diseases; Vaccine preparations.
Pharmaceutical preparations for human use; biologic preparations for medical and therapeutic purposes; Pharmaceutical preparations for human use for the treatment of central nervous system, neurological, dementia, dermatological, metabolic, hematologic, infectious, auto-immune, immune deficiency, genetic, hepatological, cardiometabolic, urological, oncological, endocrine and endocrine-related, gynecological, ophthalmological, respiratory, cardiac, and pulmonary disorders, diseases and conditions; Anti-cancer preparations; Pharmaceutical preparations and substances for the prevention of cancer; Pharmaceutical preparations and substances for the treatment of cancer; Pharmaceutical preparations for the treatment of cancer; Anti-cancer preparations of chemical origin; Anti-cancer preparations of plant origin; Anti-cancer preparations of microbial origin; Biopharmaceuticals for the treatment of cancer; Compounds for treating cancer; Biological preparations for medical purposes; Biological preparations for the treatment of cancer; Viral vaccines; Pharmaceutical preparations for the treatment of viral diseases; Pharmaceutical preparations for the treatment of inflammatory diseases; Pharmaceutical preparations for the prevention of inflammatory diseases; Pharmaceuticals; Chemico-pharmaceutical preparations; Antibacterial pharmaceuticals; Anti-microbial preparations; Chemical preparations for medical purposes; Chemical preparations for pharmaceutical purposes; Vaccines; Vaccine adjuvants; Pharmaceutical preparations comprising small molecules for degrading disease-causing cellular proteins for treatment in the field of oncology; pharmaceutical and biological preparations for treatment and prevention of cancer and for the treatment and prevention of auto-immune diseases and disorders and central nervous system and neurological diseases and disorders; Biological preparations for the treatment of viral infections; Biological preparations for the treatment of inflammatory conditions; Biological preparations for the treatment of age-related degenerative diseases; Biological preparations for the treatment of microbial, fungal and viral infections; Chemical preparations for pharmaceutical or medical purposes, namely, for the treatment of age-related degenerative diseases and cancers; Pharmaceutical preparations for the treatment and prevention of cancer; Pharmaceutical preparations for the treatment and prevention of viral infections; Pharmaceutical preparations for the treatment and prevention of microbial, fungal and viral infections; Pharmaceutical preparations for the treatment and prevention of inflammatory conditions; Pharmaceutical preparations for the treatment and prevention of age-related degenerative diseases; Vaccine preparations.
Class 42:
Scientific and technological services and research and design relating thereto; research in the fields of pharmaceutical and biologic therapeutic preparations, clinical trials and post-market trials; biomedical research and development; Research and development in the pharmaceutical and biotechnology fields; Research and development of new products; Research and development of new products for others; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research and development of vaccines and medicines; Research and development services in the field of antibodies; Biochemical research and development; Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Pharmaceutical research and development; Product research and development; Scientific research and development; Pharmaceutical product development for new small molecules aimed at degrading disease-causing cellular proteins for treatment in the field of oncology.
Scientific and technological services and research and design relating thereto; research in the fields of pharmaceutical and biologic therapeutic preparations, clinical trials and post-market trials; biomedical research and development; Research and development in the pharmaceutical and biotechnology fields; Research and development of new products; Research and development of new products for others; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research and development of vaccines and medicines; Research and development services in the field of antibodies; Biochemical research and development; Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Pharmaceutical research and development; Product research and development; Scientific research and development; Pharmaceutical product development for new small molecules aimed at degrading disease-causing cellular proteins for treatment in the field of oncology.